[Stage IV prostate cancer in Guadeloupe, a French Caribbean archipelago]

Prog Urol. 2014 Mar;24(3):167-72. doi: 10.1016/j.purol.2013.08.311. Epub 2013 Sep 27.
[Article in French]

Abstract

Objectives: To study clinical characteristics, in terms of survival and response to treatment, of patients with non-localized prostate cancer at diagnosis in an Afro-Caribbean population from Guadeloupe.

Methods: Cases of stage IV prostate cancer (T4N0M0, TxN1M0 and TxNxM1) at diagnosis in the Pointe à Pitre Hospital were selected from 1995 to 2012 and studied.

Results: One hundred and eighty-three patients were included. Median age at diagnosis was 70.3 years old (79.2% were more than 65 years). A total of 81.5% of them was TxNxM1 and 11.5% was TxN1M0. Median disease free survival was 18.5 months. Median overall survival was 49.0 months.

Conclusion: This study about non-localized prostate cancer at diagnosis in an Afro-Caribbean population from a French Caribbean archipelago seemed to show no difference with general population suffering from the same disease, although prostate cancer incidence in this area is one of the highest in the world.

Keywords: Afro-Caribbean; Afro-caribéen; Cancer; Metastatic; Métastatique; Prostate.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Guadeloupe
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / mortality
  • Prostatic Neoplasms* / therapy
  • Survival Rate
  • Treatment Outcome